Forbes November 18, 2025
UnitedHealth Group Tuesday named former U.S. Food and Drug Administration commissioner Dr. Scott Gottlieb to its board of directors.
Gottlieb, who is 53 years old, served as FDA commissioner from 2017 to 2019 during the first Trump administration and also held key roles at the Centers for Medicare & Medicaid Services during the administration of George W. Bush when the Medicare part D drug benefit was implemented.
Adding Gottlieb to UnitedHealth’s board comes at a critical time for health insurance companies as they navigate rising costs, particularly in their business administering Medicare Advantage plans. Meanwhile, health insurers are increasingly faced with the launch of new and more expensive drugs derived by biotechnology like GLP-1 drugs for weight loss.
...






